At 200 µg/mL for 7 days, chloramphenicol reduced mitochondrial MT-CO2/MT-ND3 proteins and cytochrome c oxidase maximal activity in SH-SY5Y cells and iPSC-derived forebrain neurons. Basal oxygen consumption decreased in SH-SY5Y cells but increased in the neurons; viability was comparable to untreated controls in both models. [2]
In H1299 lung cancer cells, chloramphenicol reduced cellular ATP while increasing transwell invasion. This model-specific result cautions against assuming that mitochondrial inhibition uniformly reduces cancer-cell invasive behavior. [3]
Context-dependent arrest in a cell-free translation system
Biochemical assay · Fluorescently labelled Escherichia coli ribosomes translating model mRNA; no-drug control. [1]
Chloramphenicol arrested progression at the susceptible nascent-peptide context rather than preventing all elongation steps. Toeprinting compared susceptible and non-arresting contexts.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μM for the Figure 2 smFRET experiment; 50 μM in the separate Figure 1 toeprinting validation.
- Exposure duration
- 8-minute smFRET recordings; toeprinting translation for 15 minutes.
- Method
- Cell-free translation monitored by smFRET; toeprinting used for context controls.
- Co-treatment
- Chloramphenicol alone; linezolid and thiostrepton were separate comparator conditions.
- Reported limits
- CHL stock solvent not specified in the selected methods; single-molecule n is not biological replication.
Methods and source locations
Compound reported in the paper: Chloramphenicol; Compound label in the paper: CHL
Evidence concerns the named research compound in the stated model; no Adooq sourcing or lot-specific performance is established.
Figures 1a–b and 2b–d; Results first two subsections; Online Methods: toeprinting, smFRET, statistics
Ribosomes halted at the F5 arrest site on the MFKAFK template: smFRET progression; n = 100 molecules in the CHL condition, from one experiment. Error estimated with a binomial model; n = 87 for no drug. This is not an IC50. — Results: Monitoring CHL/LZD-induced translation arrest in real time; Figure 2b–d; Online Methods: smFRET experiments and Statistics and Reproducibility
Mitochondrial effects in SH-SY5Y cells
Cell-based study · Undifferentiated human SH-SY5Y ρ+ cells versus untreated cells. [2]
Treatment reduced MT-CO2 and MT-ND3 protein and basal oxygen consumption. Trypan-blue viability was comparable to control; citrate synthase maximal activity did not significantly change.
Literature-Reported Treatment Conditions
- Treatment concentration
- 200 µg/mL
- Exposure duration
- 1 week (7 days)
- Method
- Exposure in culture; concentration maintained with medium changes.
- Co-treatment
- No additional experimental drug during the chronic chloramphenicol exposure; flux testing subsequently used mitochondrial stress-test reagents.
- Reported limits
- Chloramphenicol stock vehicle and donor-level replication are not specified in the selected treatment/statistics sections; plotted replicate counts are not inferred as independent donors.
Methods and source locations
Compound reported in the paper: Chloramphenicol; Compound label in the paper: chloramphenicol
Evidence concerns the named research compound in the stated model; no Adooq sourcing or lot-specific performance is established.
Figure 1A–B,F–I; Results 3.1; Methods 2.3–2.5,2.8,2.11–2.13
MT-CO2 and MT-ND3 protein abundance: Immunoblot densitometry normalized to β-tubulin. — Figure 1B; Results 3.1; Methods 2.5
Basal OCR and COX maximal activity: Seahorse flux normalized to cell count; spectrophotometric COX activity. Approximate percentage is from Results prose, not digitized. — Figure 1F,H; Results 3.1; Methods 2.11–2.13
Mitochondrial effects in iPSC-derived forebrain neurons
Cell-based study · Mature human forebrain neurons derived from an APOE ε3/ε3 fibroblast-derived iPSC line (JIPSC1268), versus untreated neurons. [2]
MT-CO2 and MT-ND3 protein and COX maximal activity decreased, but basal oxygen consumption increased. Basal extracellular acidification and viability were comparable to control; citrate synthase activity increased.
Literature-Reported Treatment Conditions
- Treatment concentration
- 200 µg/mL
- Exposure duration
- 1 week (7 days)
- Method
- Exposure in culture; concentration maintained with medium changes.
- Co-treatment
- No additional experimental drug during the chronic chloramphenicol exposure; flux testing subsequently used mitochondrial stress-test reagents.
- Reported limits
- Chloramphenicol stock vehicle and donor-level replication are not specified in the selected treatment/statistics sections; plotted replicate counts are not inferred as independent donors.
Methods and source locations
Compound reported in the paper: Chloramphenicol; Compound label in the paper: chloramphenicol
Evidence concerns the named research compound in the stated model; no Adooq sourcing or lot-specific performance is established.
Figure 5A–B,H–K; Results 3.4; Methods 2.1–2.2,2.4–2.5,2.8,2.11–2.13
MT-CO2 and MT-ND3 protein abundance: Immunoblot densitometry normalized to β-tubulin. — Figure 5B; Results 3.4; Methods 2.5
Basal OCR and COX maximal activity: Seahorse flux normalized to cell count; spectrophotometric COX assay. The 40% statement is from Results prose. — Figure 5H,J; Results 3.4; Methods 2.11–2.13
Metabolic restriction and increased H1299 cell invasion
Cell-based study · Human H1299 non-small-cell lung cancer cells; zero-chloramphenicol controls; rotenone used separately as an ATP-assay positive control. [3]
Chloramphenicol decreased Cox I protein and cellular ATP, while increasing Matrigel transwell invasion. These results limit any general assertion that mitochondrial inhibition necessarily suppresses tumor-cell invasion.
Literature-Reported Treatment Conditions
- Treatment concentration
- ATP: 10, 20 and 100 μg/mL; invasion and Cox I: 20 and 100 μg/mL, with zero-CHL controls.
- Method
- Cell exposure followed by ATP assay, Cox I immunoblotting and transwell invasion assessment.
- Vehicle
- Ethanol; solvent content < 5 μL/mL in all experiments.
- Co-treatment
- CHL alone in the adopted conditions; rotenone was a separate ATP-assay comparator.
- Reported limits
- Figure 1 and its caption do not specify endpoint-specific treatment duration. Common invasion methods give 12–48 h, without assigning an exact interval to Figure 1C. Vehicle matching for zero-CHL wells is not explicitly stated.
Methods and source locations
Compound reported in the paper: Chloramphenicol; Compound label in the paper: chloramphenicol
Evidence concerns the named research compound in the stated model; no Adooq sourcing or lot-specific performance is established.
Figure 1A–C; first Results subsection; Materials and Methods: chemicals/cell culture, ATP, Western blot, invasion and statistics
Cellular ATP content: ATP bioluminescence; mean ± SD from at least three independent experiments under the common statistics statement. Exact bar heights not transcribed. — Figure 1B; first Results subsection; Materials and Methods: Cellular ATP content measurement and Statistical analysis
Invaded H1299 cells per chamber: Matrigel-coated transwell assay; mean ± SD, at least three independent experiments under common statistics statement. — Figure 1C; first Results subsection; Materials and Methods: In vitro invasion assay and Statistical analysis